FindTrial
Sign In

Effect of mulligan mobilization and soft tissue release on diaphragm excursion in mild to moderate asthma

Effect of thoracic mulligan mobilization with Soft tissue release on respiratory parameters including diaphragmatic excursion on motion ultrasound and quality of life in mild to moderate asthma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036910
Enrollment
36
Registered
2021-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: Mulligan mobilization and Soft tissue release: Participants will receive Mulligan mobilization and Soft tissue release for 9 sessions 3days/week for 3 weeks Control Intervention1: Not a

Sponsors

KAHER Institute of Physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mild Asthma: Peak expiratory flow >90% of normal Moderate asthma: Peak expiratory flow 80- 90% of normal Medically stable Willingness to participate

Exclusion criteria

Exclusion criteria: Other respiratory and cardiovascular disorders Presence of other thoracic cage or upper limb neurological,musculoskeletal or autoimmune condition Metabolic bone disorders

Design outcomes

Primary

MeasureTime frame
Motion ultrasound Peak flow meter SF 36 Questionnaire Chest expansion tape measurementTimepoint: Pre and post assessment willing be taken on day 1 and after 3 weeks and total 9 sessions of thoracic Mulligan mobilization and soft tissue release—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactAnuja Bankar

KAHER Institute of Physiotherapy

santoshmetgud@klekipt.edu.in9880088400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026